Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study - Wikidata - awgldk - TriplyDB

Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study

Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study

http://www.wikidata.org/entity/Q33643975

about

Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study

http://www.wikidata.org/entity/Q33643975

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Continuous use of low-dose war ...... issection: a prospective study

@ast

Continuous use of low-dose war ...... issection: a prospective study

@en

type

label

Continuous use of low-dose war ...... issection: a prospective study

@ast

Continuous use of low-dose war ...... issection: a prospective study

@en

prefLabel

Continuous use of low-dose war ...... issection: a prospective study

@ast

Continuous use of low-dose war ...... issection: a prospective study

@en

P1433

Q33643975-29A0C829-BFF6-4DEC-9EDF-DACDF4C02755

P1476

Q33643975-73A1E362-F661-4999-8EC6-99AB610EB53B

P2093

Q33643975-09863BC8-3C96-486E-B28D-D6238E9A0B7C

Q33643975-32D8F89D-ABE7-4ACB-9F33-009A285B42FE

Q33643975-4BD5634D-C735-4E1A-9EAF-09CD2602B53E

Q33643975-611629A4-7D18-49E4-83F7-4DB755DD7164

Q33643975-64CAD640-69D3-4B9B-A81B-EC066B390E79

Q33643975-6A7BF4E7-0BA7-436C-94F1-9F39C5CD80F2

Q33643975-6D6B74EE-D130-438C-8C86-2D0EB9B98DA1

Q33643975-96302D3C-FD83-4C98-85CD-484BDD817C01

Q33643975-D1C466AB-EE69-458A-94F8-27D8D3FC1ADE

P2860

Q33643975-0BF98BB7-9605-4E06-A917-D0D27D91964A

Q33643975-210FD71C-C942-4D5B-81C2-6A4DA0D37635

Q33643975-405C6147-A74F-4A2A-87C9-C1EF39C99798

Q33643975-4F1E6914-DBF2-4318-8633-95B86814681A

Q33643975-55DB6141-96DA-4892-A729-2DA1F8458D63

Q33643975-63A832E7-62B1-4231-B862-B6D5CB1E7F2D

Q33643975-65DE9C66-C0B9-4C83-8AC9-594F8532E86F

Q33643975-73DA0D38-2436-4695-8058-F42E6A1BB5B6

Q33643975-782CE410-EA99-468A-9493-C44D7549908D

Q33643975-7A1B2B13-A5AD-4593-8CF0-72B950CC4C8F

P304

Q33643975-BB72C6D0-CE02-46C4-99A3-500E9CAC26FC

P31

Q33643975-33384D70-8727-4FE0-B520-D5394ACADE15

P356

Q33643975-0AC38DA1-A677-4B51-919B-F2ACAA1103CD

P433

Q33643975-3D764E3E-C679-47CC-A251-2BEA9A032CF3

P478

Q33643975-1CF83D34-965A-4F3A-A959-512455E7FF48

P577

Q33643975-7A13D618-0962-4A09-A44B-FF636E8B91B2

P698

Q33643975-E377DE96-E8F3-4DB1-9EFD-4B5F62AFEA50

P932

Q33643975-9A4F16A1-C36B-44EC-911F-417115D14106

P356

P1433

Endoscopy international open

P1476

Continuous use of low-dose war ...... issection: a prospective study

@en

P2093

Daisuke Murakami

http://www.w3.org/2001/XMLSchema#string

Hideaki Harada

http://www.w3.org/2001/XMLSchema#string

Kenji Hayasaka

http://www.w3.org/2001/XMLSchema#string

Ryotaro Nakahara

http://www.w3.org/2001/XMLSchema#string

Satoshi Suehiro

http://www.w3.org/2001/XMLSchema#string

Shigetaka Tounou

http://www.w3.org/2001/XMLSchema#string

Takanori Shimizu

http://www.w3.org/2001/XMLSchema#string

Yasunaga Miyama

http://www.w3.org/2001/XMLSchema#string

Yasushi Katsuyama

http://www.w3.org/2001/XMLSchema#string

P2860

Primary prevention of ischemic stroke

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases

Validation of Clinical Classification Schemes for Predicting Stroke

Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.

Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents

Gastric ESD under Heparin Replacement at High-Risk Patients of Thromboembolism Is Technically Feasible but Has a High Risk of Delayed Bleeding: Osaka University ESD Study Group.

Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.

Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat

P304

E348-E353

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0043-105493

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28484736

http://www.w3.org/2001/XMLSchema#string

P932

5419842

http://www.w3.org/2001/XMLSchema#string